BioSpace News Archive

One Call, the nation’s leading provider of specialized healthcare solutions for the workers’ compensation industry, announced today that it has finalized a financial transaction resulting in an additional $150 million of liquidity over the next five years.

“I use ABG kits with my work as a respiratory therapist,” said an inventor from Lodi, Calif. “I thought that there had to be a better way to keep ABG cold.”

“I wanted to create an improved way to protect children and prevent other family members or visitors from accessing medications in the medicine cabinet,” said an inventor, from Winters, Calif., “so I invented the SECURE MEDICINE CABINET.”

Ashley Addiction Treatment (Ashley), one of the world’s most respected names in the substance use disorder treatment industry, has named Becky Kiersznowski as Vice President of Clinical Services. In this newly created position, Kiersznowski will oversee Ashley’s clinical services in each level of care.

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the initiation and opening of sites to enroll the second portion of the company’s Phase 3 program for VGX-3100, Inovio’s DNA-based immunotherapy to treat cervical dysplasia caused by human papillomavirus (HPV)

In conjunction with DURECT Corporation’s (Nasdaq: DRRX) fourth quarter 2018 financial results press release, you are invited to listen to a conference call that will be broadcast live over the internet on Thursday, March 7, 2019 at 4:30 pm Eastern Time (1:30 pm Pacific Time).

Panaxia in collaboration with the Israeli Pharmaceutical company “Rafa”, has begun a clinical research of medical cannabis concentrates for inhalation.

MedX Health Corp. announces that it has signed an agreement with Richmar, a Compass Health Brands Company, to manufacture and supply selected Private Label Laser and Light products to Richmar for the US rehabilitation market.

BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, announced today that Francois Binette, PhD, Senior Vice President and Global Head of Product Development at BioTime, Inc., will present the 14th Annual Scientific Meeting of the Association For Ocular Pharmacology and Therapeutics

The Honourable Ginette Petitpas Taylor, federal Minister of Health, will make a funding announcement to support health-based education.